| Schedule of Earnings (Loss) Per Share, Basic and Diluted |
The following table sets forth the computation of the Company’s basic and diluted earnings (loss) per share: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | June 27,
2026 | | June 28,
2025 | | June 27,
2026 | | June 28,
2025 | | (In thousands, except share and per share data) | | | | | | | | | Numerator: | | | | | | | | Net income (loss) - basic and diluted | $ | 29,853 | | | $ | (3,379) | | | $ | 94,765 | | | $ | (23,286) | | | Denominator: | | | | | | | | | Weighted-average shares of common stock—basic | 118,961,126 | | 120,423,439 | | 119,886,795 | | | 120,804,730 | | | Effect of potentially dilutive stock options | 177,925 | | | — | | | 463,941 | | | — | | | Effect of RSUs | 1,515,696 | | | — | | | 2,141,697 | | | — | | | Effect of PSUs | 327,757 | | | — | | | 269,274 | | | — | | | Weighted-average shares of common stock—diluted | 120,982,504 | | 120,423,439 | | 122,761,707 | | | 120,804,730 | | Earnings (loss) per share: | | | | | | | | | Basic | $ | 0.25 | | | $ | (0.03) | | | $ | 0.79 | | | $ | (0.19) | | | Diluted | $ | 0.25 | | | $ | (0.03) | | | $ | 0.77 | | | $ | (0.19) | |
|
| Schedule of Antidilutive Securities |
The following shares were excluded from the computation of diluted net earnings (loss) per share because their effect would have been antidilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | June 27,
2026 | | June 28,
2025 | | June 27,
2026 | | June 28,
2025 | | Stock options to purchase common stock | 4,054,557 | | 6,338,165 | | 4,167,719 | | 6,673,403 | | Restricted stock units | 7,378,209 | | 10,863,006 | | 6,379,624 | | 13,394,270 | | Performance stock units | 912,952 | | 516,697 | | 468,578 | | 201,691 | | Total | 12,345,718 | | 17,717,868 | | 11,015,921 | | 20,269,364 |
|